Abstract: The present invention relates to agrochemical compositions: their use for foliar application; their use at low spray volumes; their use by unmanned aerial systems (UAS), unmanned guided vehicles (UGV), and tractor mounted boom sprayers fitted with conventional nozzles but also pulse width modulation spray nozzles or rotating disc droplet applicators; and their application for controlling agricultural pests, weeds or diseases, in particular on waxy leaves, and in particular the present invention relates to agrochemical compositions with a reduced drift, in particular in spray applications.

Abstract: The present invention relates to agrochemical compositions; their use for foliar application; their use at low spray volumes; their use by unmanned aerial systems (UAS), unmanned guided vehicles (UGV), and tractor mounted boom sprayers fitted with conventional nozzles but also pulse width modulation spray nozzles or rotating disc droplet applicators; and their application for controlling agricultural pests, weeds or diseases, in particular on waxy leaves, and in particular the present invention relates to agrochemical compositions with a reduced drift, in particular in spray applications, and good spreading and uptake properties.

Abstract: Low drift, rainfastness, high uptake and ULV tank mix adjuvant formulation The instant invention refers to a tank mix adjuvant formulation comprising providing improved drift, high uptake and rainfastness to an agrochemical formulation comprising at least one agrochemical pesticide. Further the invention is directed to the tank mix of an agrochemical formulation comprising at least one pesticide with the adjuvant combination, as well as the use of both the adjuvant formulation and the ready tank mix for ULV applications and conventional spray volume applications.

Abstract: The present invention relates to agrochemical compositions: their use for foliar application; their use at low spray volumes; their use by unmanned aerial systems (UAS), unmanned guided vehicles (UGV), and tractor mounted boom sprayers fitted with conventional nozzles but also pulse width modulation spray nozzles or rotating disc droplet applicators; and their application for controlling agricultural pests, weeds or diseases, in particular on waxy leaves, and in particular the present invention relates to agrochemical compositions with a reduced drift, in particular in spray applications.

Abstract: The present invention relates to agrochemical compositions: their use for foliar application; their use at low spray volumes; their use by unmanned aerial systems (UAS), unmanned guided vehicles (UGV), and tractor mounted boom sprayers fitted with conventional nozzles but also pulse width modulation spray nozzles or rotating disc droplet applicators; and their application for controlling agricultural pests, weeds or diseases, in particular on waxy leaves, and in particular the present invention relates to agrochemical compositions with a reduced drift, in particular in spray applications.

Abstract: The present invention relates to agricultural adjuvant compositions for tank-mixture with crop protection products: their use for foliar application; their use at low spray volumes; their use by unmanned aerial systems (UAS), unmanned guided vehicles (UGV), and tractor mounted boom sprayers fitted with conventional nozzles but also pulse width modulation spray nozzles or rotating disc droplet applicators; and their application for controlling agricultural pests, weeds or diseases, in particular on waxy leaves.

Abstract: The present invention relates to the use of oil based suspo-emulsion concentrates which reduce drift during spray application. The oil based suspo-emulsion concentrates are usually diluted with water and optionally further supplemented with additional additives. The spray liquid so obtained is then sprayed and is especially applicable for spraying using conventional hydraulic nozzles.

Abstract: Systems, methods, and computer-readable media for a healthcare management service are provided.

Abstract: Robotic pill dispensers are described. A robotic pill dispenser may include a main body forming a cavity and comprising an inlet port and an outlet port. The pill dispenser may further include a container assembly disposed in the cavity of the main body. The container assembly may include a container body and a plurality of blades fastened to the container body and dividing the container assembly into a plurality of compartments. The plurality of blades may be movable relative to the container body. The pill dispenser may further comprise a processor configured to control the pill dispenser to align a first compartment of the plurality of compartments to the outlet port, determine whether one or more medications are present in the first compartment, and control the mechanical actuator to shake at least a portion of the pill dispenser.

Abstract: Systems, methods, and computer-readable media for a healthcare management service are provided.

Abstract: Systems, methods, and computer-readable media for a healthcare management service are provided.

Abstract: Systems, methods, and computer-readable media for a healthcare management service are provided.

Abstract: Systems, methods, and computer-readable media for a healthcare management service are provided.

Abstract: A method for inhibiting the formation or agglomeration of gas hydrates in a system, said method comprising adding to the system a compound of formula (I) or a zwitterionic form thereof wherein R1 is a group comprising 4 to 28 carbon atoms and at least one C?C double bond; L1 and L2 are independently selected from bonds and linker moieties containing 1 to 12 carbon atoms; and R2, R3, R4, R5, R6, R7, R8, R9 and R10 are independently H or a group comprising 1-20 carbon atoms.

Abstract: The invention relates to panels of biomarkers including proteins phosphatase 1 regulatory subunit 14A and/or 2?,3?-cyclic-nucleotide 3?-phosphodiesterase and/or phosphorylated tau or fragments thereof and methods using thereof for diagnosing, staging, treating and assessing the response of a treatment for a neurocognitive disorder characterised by tau toxicity, in particular for Alzheimer's disease. The present invention shows that the biomarkers disclosed herein are elevated in the brain of subjects with an advanced stage of a neurocognitive disorder (Braak stage V/VI) and/or are regulated in the CSF of AD subjects in comparison to cognitively affected non-AD controls; and/or regulated in response to two casein kinase 1 delta inhibitors.

Abstract: Alzheimer's disease, the most common cause of dementia in older individuals, is a debilitating neurodegenerative disease for which there is currently no cure. In the past, AD could only be definitively diagnosed by brain biopsy or upon autopsy after a patient died. These methods, which demonstrate the presence of the characteristic plaque and tangle lesions in the brain, are still considered the gold standard for the pathological diagnoses of AD. However, in the clinical setting brain biopsy is rarely performed and diagnosis depends on a battery of neurological, psychometric and biochemical tests, including the measurement of biochemical markers such as the ApoE and tau proteins or the beta-amyloid peptide in cerebrospinal fluid and blood. The present invention discloses and describes panels of makers that are differentially expressed in the disease state relative to their expression in the normal state and, in particular, identifies and describes panels of makers associated with neurocognitive disorders.

Abstract: The invention relates to materials and methods for diagnosing liver tumor types, and assessing patient prognosis. Specifically, but not exclusively, the invention concerns the determination of marker protein which enable primary liver tumors to be identified and classified according to the latest WHO classification. Particularly, the invention provides potential markers proteins which allow non-neoplastic and neoplastic hepatocytes and biliary epithelial cells to be distinguished. This allows grading of tumor differentiation to be refined and differential diagnosis of primary liver tumors and pathogenesis of sub-types of cholangiocarcinoma.

Abstract: The present invention provides a method for diagnosing or assessing a neurodegenerative disease in a test subject, comprising: (i) providing a protein-containing sample that has been obtained from the test subject; (ii) determining the concentration, amount or degree of expression of at least one specific protein isoform and/or glycoform derived from a protein biomarker selected from the group consisting of: clusterin precursor; apolipoprotein A-IV precursor; apolipoprotein C-III precursor; transthyretin; galectin 7; complement C4 precursor; alpha-2-macroglobulin precursor; Ig alpha-1 chain C; histone 2B; Ig lambda chain C region; fibrinogen gamma chain precursor; complement factor H; inter-alpha-trypsin heavy chain H4 precursor; complement C3 precursor; gamma or beta actin; haptoglobin precursor; and the serum albumin precursor, or a fragment thereof; (iii) comparing said concentration, amount or degree determined in (ii) with a reference from a control subject with a specific neurodegenerative disease, deme

Abstract: The invention relates to methods and compositions relating Alzheimer's disease. There is provided a panel of optimal biomarkers which allow diagnosis of Alzheimer's disease and discrimination between Alzheimer's disease and its earlier precursor, mild cognitive impairment (MCI).

Abstract: The present invention relates to methods of inhibiting the formation or agglomeration of gas hydrates using amidines or guanidines. The invention further relates to compositions comprising amidines or guanidines that find use as gas hydrate inhibitors, as well as processes for preparing alkylated amidinium or guanidinium salts.